• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    AVM Biotechnology Selected by the National Cancer Institute to Present

    11 Sep 2023 //

    BUSINESSWIRE

    AVM Biotechnology Announces that the National Cancer Institute has selected AVM Biotechnology as a Showcase Company for their 2023-2024 Small Business Innovation Research (SBIR) Investor Initiatives

    09 Aug 2023 //

    BUSINESSWIRE

    AVM Bio Announces Solid Tumor & Blood Cancer Patients Treated with AVM0703

    01 Aug 2023 //

    BUSINESSWIRE

    AVM Biotech Awarded $2M NCI SBIR PII Grant from NIH to Advance AVM0703

    14 Jun 2022 //

    BUSINESSWIRE

    AVM Biotechnology to Present Poster Highlighting the Effects of AVM0703

    01 Jun 2022 //

    BUSINESSWIRE

    AVM Bio Founder and CSO to Present Company Information and Trial Progress

    19 Apr 2022 //

    BUSINESSWIRE

    AVM Biotechnology Awarded $1.6M Phase II SBIR Grant to Study AVM0703’s Potential

    05 Apr 2022 //

    BUSINESSWIRE

    AVM Biotech Expands C-Suite in Anticipation of 2023 Commercialization Efforts

    09 Mar 2022 //

    BUSINESSWIRE

    FDA Approves Accelerated Dosing in Non-Hodgkin`s Lymphoma/Leukemia

    13 Jul 2021 //

    PRNEWSWIRE

    AVM Announces Full Enrollment of First Cohort of Relapsed/Refractory

    07 Apr 2021 //

    PRNEWSWIRE

    Seattle AVM Biotechnology announces second IND for AVM0703

    16 Sep 2020 //

    BIOSPACE

    AVM Biotechnology Expands Executive Team in Preparation Onco & COVID-19 Trials

    08 Jul 2020 //

    PRNEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.